Author

Di Wang

Institutions: Praxis Spinal Cord Institute, EVERSANA (Canada)

Observed institutions: Praxis Spinal Cord Institute, EVERSANA (Canada)

ORCID: 0009-0006-2084-3680

Observed ORCID: 0009-0006-2084-3680

OpenAlex ID: A5144386101

A mortality model for relapsed or refractory multiple myeloma: emulation of subjective life expectancy criteria from a clinical trial in real-world data

2026 · Alexander Breskin, Mostafa Shokoohi, et al. · Annals of Hematology · 1

Effects of concomitant traumatic brain injury on the epidemiology, access to treatment services and outcomes after traumatic spinal cord injury: A retrospective cohort study

2026 · Julio C. Furlan, Di Wang, et al. · Spinal Cord · 1

Effectiveness of linvoseltamab versus real-world standard-of-care in triple-class-exposed relapsed/refractory multiple myeloma in the United States

2026 · Shaji Kumar, Katja C. Weisel, et al. · Blood Cancer Journal · 1

Works count: 3

Citation count: 3

H-index: 1

I10-index: